1 | Study | 1.79% | |
2 | Patients | 0.89% | |
3 | Cancer | 0.89% | |
4 | New | 0.89% | |
5 | Asia | 0.89% | |
6 | Screens | 0.6% | |
7 | Infection | 0.6% | |
8 | HPV | 0.6% | |
9 | Kidney | 0.6% | |
10 | Diabetes | 0.6% | |
11 | Therapy | 0.6% | |
12 | Risk | 0.6% | |
13 | Safety | 0.6% | |
14 | Inflammation | 0.6% | |
15 | Case | 0.6% | |
16 | Artery | 0.6% | |
17 | Pacific | 0.6% | |
18 | China | 0.6% | |
19 | Young | 0.6% | |
20 | Cell | 0.6% | |
21 | Induced | 0.6% | |
22 | Disease | 0.6% | |
23 | Era | 0.6% | |
24 | Boosts | 0.3% | |
25 | Drinks | 0.3% | |
26 | LivaNova’s | 0.3% | |
27 | Some | 0.3% | |
28 | Saccharin | 0.3% | |
29 | Pathogen | 0.3% | |
30 | Effectively | 0.3% | |
31 | Gut | 0.3% | |
32 | Tolerance | 0.3% | |
33 | Strategies | 0.3% | |
34 | Endocrine | 0.3% | |
35 | Tied | 0.3% | |
36 | Cardiobacterium | 0.3% | |
37 | Approval | 0.3% | |
38 | Hyponatremia | 0.3% | |
39 | Office | 0.3% | |
40 | Effectiveness | 0.3% | |
41 | Non-occlusive | 0.3% | |
42 | Resistance | 0.3% | |
43 | Day | 0.3% | |
44 | Evidence | 0.3% | |
45 | Detection | 0.3% | |
46 | Antidepressant | 0.3% | |
47 | Spread | 0.3% | |
48 | NR2F2 | 0.3% | |
49 | Syndrome | 0.3% | |
50 | Drug | 0.3% | |
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|